
@article{kikuchi2021,
	title = {Discovery research and development history of the dopamine D {\textsubscript{2}} receptor partial agonists, aripiprazole and brexpiprazole},
	author = {Kikuchi, Tetsuro and Maeda, Kenji and Suzuki, Mikio and Hirose, Tsuyoshi and Futamura, Takashi and McQuade, Robert D.},
	year = {2021},
	month = {06},
	date = {2021-06},
	journal = {Neuropsychopharmacology Reports},
	pages = {134--143},
	volume = {41},
	number = {2},
	doi = {10.1002/npr2.12180},
	url = {https://onlinelibrary.wiley.com/doi/10.1002/npr2.12180},
	langid = {en}
}

@article{alex2007,
	title = {Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission},
	author = {Alex, K. D. and Pehek, E. A.},
	year = {2007},
	month = {02},
	date = {2007-02},
	journal = {Pharmacology & Therapeutics},
	pages = {296--320},
	volume = {113},
	number = {2},
	doi = {10.1016/j.pharmthera.2006.08.004},
	note = {PMID: 17049611
PMCID: PMC2562467},
	langid = {eng}
}

@article{han2009,
	title = {The effects of antipsychotic drugs administration on 5-HT1A receptor expression in the limbic system of the rat brain},
	author = {Han, M. and Huang, X.F. and du Bois, T.M. and Deng, C.},
	year = {2009},
	month = {12},
	date = {2009-12},
	journal = {Neuroscience},
	pages = {1754--1763},
	volume = {164},
	number = {4},
	doi = {10.1016/j.neuroscience.2009.09.041},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0306452209015164},
	langid = {en}
}

@article{pae2011,
	title = {Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data},
	author = {Pae, Chi-Un and Forbes, Andy and Patkar, Ashwin A.},
	year = {2011},
	month = {02},
	date = {2011-02},
	journal = {CNS drugs},
	pages = {109--127},
	volume = {25},
	number = {2},
	doi = {10.2165/11538980-000000000-00000},
	note = {PMID: 21254788},
	langid = {eng}
}

@article{mailman2010,
	title = {Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?},
	author = {Mailman, Richard B. and Murthy, Vishakantha},
	year = {2010},
	date = {2010},
	journal = {Current Pharmaceutical Design},
	pages = {488--501},
	volume = {16},
	number = {5},
	doi = {10.2174/138161210790361461},
	note = {PMID: 19909227
PMCID: PMC2958217},
	langid = {eng}
}

@article{fagiolini2015,
	title = {Switching antipsychotic medication to aripiprazole: position paper by a panel of Italian psychiatrists},
	author = {Fagiolini, Andrea and Brugnoli, Roberto and Di Sciascio, Guido and De Filippis, Sergio and Maina, Giuseppe},
	year = {2015},
	month = {04},
	date = {2015-04},
	journal = {Expert Opinion on Pharmacotherapy},
	pages = {727--737},
	volume = {16},
	number = {5},
	doi = {10.1517/14656566.2015.1013029},
	note = {PMID: 25672664},
	langid = {eng}
}

@article{janicak2009,
	title = {The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies},
	author = {Janicak, Philip G. and Glick, Ira D. and Marder, Stephen R. and Crandall, David T. and McQuade, Robert D. and Marcus, Ronald N. and Eudicone, James M. and {Assunção-Talbott}, Sheila},
	year = {2009},
	month = {01},
	date = {2009-01},
	journal = {The Journal of Clinical Psychiatry},
	pages = {25--35},
	volume = {70},
	number = {1},
	doi = {10.4088/jcp.08m04310},
	note = {PMID: 19192472},
	langid = {eng}
}

@article{kane2002,
	title = {Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder},
	author = {Kane, John M. and Carson, William H. and Saha, Anutosh R. and McQuade, Robert D. and Ingenito, Gary G. and Zimbroff, Dan L. and Ali, Mirza W.},
	year = {2002},
	month = {09},
	date = {2002-09},
	journal = {The Journal of Clinical Psychiatry},
	pages = {763--771},
	volume = {63},
	number = {9},
	doi = {10.4088/jcp.v63n0903},
	note = {PMID: 12363115},
	langid = {eng}
}

@article{potkin2003,
	title = {Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder},
	author = {Potkin, Steven G. and Saha, Anutosh R. and Kujawa, Mary J. and Carson, William H. and Ali, Mirza and Stock, Elyse and Stringfellow, Joseph and Ingenito, Gary and Marder, Stephen R.},
	year = {2003},
	month = {07},
	date = {2003-07},
	journal = {Archives of General Psychiatry},
	pages = {681--690},
	volume = {60},
	number = {7},
	doi = {10.1001/archpsyc.60.7.681},
	note = {PMID: 12860772},
	langid = {eng}
}

@article{disciascio2015,
	title = {Aripiprazole: from pharmacological profile to clinical use},
	author = {Di Sciascio, Guido and Riva, Marco Andrea},
	year = {2015},
	date = {2015},
	journal = {Neuropsychiatric Disease and Treatment},
	pages = {2635--2647},
	volume = {11},
	doi = {10.2147/NDT.S88117},
	note = {PMID: 26508859
PMCID: PMC4610784},
	langid = {eng}
}

@article{qian2021,
	title = {Dose-Dependent Efficacy of Aripiprazole in Treating Patients With Schizophrenia or Schizoaffective Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials},
	author = {Qian, Li and Xuemei, Liao and Jitao, Li and {Yun'Ai}, Su and Tianmei, Si},
	year = {2021},
	month = {08},
	date = {2021-08-11},
	journal = {Frontiers in Psychiatry},
	pages = {717715},
	volume = {12},
	doi = {10.3389/fpsyt.2021.717715},
	url = {https://www.frontiersin.org/articles/10.3389/fpsyt.2021.717715/full}
}

@article{sensky2000,
	title = {A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication},
	author = {Sensky, T. and Turkington, D. and Kingdon, D. and Scott, J. L. and Scott, J. and Siddle, R. and {O'Carroll}, M. and Barnes, T. R.},
	year = {2000},
	month = {02},
	date = {2000-02},
	journal = {Archives of General Psychiatry},
	pages = {165--172},
	volume = {57},
	number = {2},
	doi = {10.1001/archpsyc.57.2.165},
	note = {PMID: 10665619},
	langid = {eng}
}

@article{brown2013,
	title = {Aripiprazole alone or in combination for acute mania},
	author = {Brown, Rachel and Taylor, Matthew J. and Geddes, John},
	year = {2013},
	month = {12},
	date = {2013-12-17},
	journal = {The Cochrane Database of Systematic Reviews},
	pages = {CD005000},
	number = {12},
	doi = {10.1002/14651858.CD005000.pub2},
	note = {PMID: 24346956},
	langid = {eng}
}

@article{keck2007,
	title = {Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo},
	author = {Keck, Paul E. and Calabrese, Joseph R. and McIntyre, Roger S. and McQuade, Robert D. and Carson, William H. and Eudicone, James M. and Carlson, Berit X. and Marcus, Ronald N. and Sanchez, Raymond and Aripiprazole Study Group, },
	year = {2007},
	month = {10},
	date = {2007-10},
	journal = {The Journal of Clinical Psychiatry},
	pages = {1480--1491},
	volume = {68},
	number = {10},
	doi = {10.4088/jcp.v68n1003},
	note = {PMID: 17960961},
	langid = {eng}
}

@article{kim2021,
	title = {Efficacy and tolerability of aripiprazole versus D2 antagonists in the early course of schizophrenia: a systematic review and meta-analysis},
	author = {Kim, David D. and Barr, Alasdair M. and Lian, Lulu and Yuen, Jessica W. Y. and Fredrikson, Diane and Honer, William G. and Thornton, Allen E. and Procyshyn, Ric M.},
	year = {2021},
	month = {12},
	date = {2021-12},
	journal = {npj Schizophrenia},
	pages = {29},
	volume = {7},
	number = {1},
	doi = {10.1038/s41537-021-00158-z},
	url = {http://www.nature.com/articles/s41537-021-00158-z},
	langid = {en}
}

@article{lea2007,
	title = {Agitation associated with aripiprazole initiation},
	author = {Lea, Jessica W. and Stoner, Steven C. and Lafollette, Jeremy},
	year = {2007},
	month = {09},
	date = {2007-09},
	journal = {Pharmacotherapy},
	pages = {1339--1342},
	volume = {27},
	number = {9},
	doi = {10.1592/phco.27.9.1339},
	note = {PMID: 17723088},
	langid = {eng}
}

@article{basu2006,
	title = {Dose-dependent rapid-onset akathisia with aripiprazole in patients with schizoaffective disorder},
	author = {Basu, Ranita and Brar, Jaspreet S.},
	year = {2006},
	month = {06},
	date = {2006-06},
	journal = {Neuropsychiatric Disease and Treatment},
	pages = {241--243},
	volume = {2},
	number = {2},
	doi = {10.2147/nedt.2006.2.2.241},
	note = {PMID: 19412470
PMCID: PMC2671776},
	langid = {eng}
}

@article{vergouwen2005,
	title = {['Awakening': a confusing improvement during treatment with atypical antipsychotic agents]},
	author = {Vergouwen, A. C. M. and de Bruijn, C. and Been, A.},
	year = {2005},
	month = {07},
	date = {2005-07-30},
	journal = {Nederlands Tijdschrift Voor Geneeskunde},
	pages = {1717--1720},
	volume = {149},
	number = {31},
	note = {PMID: 16114284},
	langid = {dut}
}

@article{poyurovsky2010,
	title = {Acute antipsychotic-induced akathisia revisited},
	author = {Poyurovsky, Michael},
	year = {2010},
	month = {02},
	date = {2010-02},
	journal = {The British Journal of Psychiatry: The Journal of Mental Science},
	pages = {89--91},
	volume = {196},
	number = {2},
	doi = {10.1192/bjp.bp.109.070540},
	note = {PMID: 20118449},
	langid = {eng}
}

@article{thomas2015,
	title = {The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis},
	author = {Thomas, Jennifer E. and Caballero, Joshua and Harrington, Catherine A.},
	year = {2015},
	date = {2015},
	journal = {Current Neuropharmacology},
	pages = {681--691},
	volume = {13},
	number = {5},
	doi = {10.2174/1570159x13666150115220221},
	note = {PMID: 26467415
PMCID: PMC4761637},
	langid = {eng}
}

@article{sullivan2007,
	title = {Practical prescribing with aripiprazole in schizophrenia: consensus recommendations of a UK multidisciplinary panel},
	author = {Sullivan, Gary and Bienroth, Markus and Jones, Martin and Millar, Helen and Ratna, Lawrence and Taylor, David},
	year = {2007},
	month = {07},
	date = {2007-07},
	journal = {Current Medical Research and Opinion},
	pages = {1733--1744},
	volume = {23},
	number = {7},
	doi = {10.1185/030079907x210633},
	note = {PMID: 17588303},
	langid = {eng}
}

@article{mago2008,
	title = {Proposed strategies for successful clinical management with aripiprazole},
	author = {Mago, Rajnish},
	year = {2008},
	month = {06},
	date = {2008-06},
	journal = {Expert Opinion on Pharmacotherapy},
	pages = {1279--1290},
	volume = {9},
	number = {8},
	doi = {10.1517/14656566.9.8.1279},
	url = {http://www.tandfonline.com/doi/full/10.1517/14656566.9.8.1279},
	langid = {en}
}

@article{casey2003,
	title = {Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study},
	author = {Casey, Daniel E. and Carson, William H. and Saha, Anutosh R. and Liebeskind, Amy and Ali, Mirza W. and Jody, Darlene and Ingenito, Gary G. and Aripiprazole Study Group, },
	year = {2003},
	month = {04},
	date = {2003-04},
	journal = {Psychopharmacology},
	pages = {391--399},
	volume = {166},
	number = {4},
	doi = {10.1007/s00213-002-1344-3},
	note = {PMID: 12610718},
	langid = {eng}
}

@article{yokoi2002,
	title = {Dopamine D2 and D3 Receptor Occupancy in Normal Humans Treated with the Antipsychotic Drug Aripiprazole (OPC 14597) A Study Using Positron Emission Tomography and [11C]Raclopride},
	author = {Yokoi, F},
	year = {2002},
	month = {08},
	date = {2002-08},
	journal = {Neuropsychopharmacology},
	pages = {248--259},
	volume = {27},
	number = {2},
	doi = {10.1016/S0893-133X(02)00304-4},
	url = {http://www.nature.com/doifinder/10.1016/S0893-133X(02)00304-4}
}

@article{natesan2006,
	title = {Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models},
	author = {Natesan, Sridhar and Reckless, Greg E. and Nobrega, {José N.} and Fletcher, Paul J. and Kapur, Shitij},
	year = {2006},
	month = {09},
	date = {2006-09},
	journal = {Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology},
	pages = {1854--1863},
	volume = {31},
	number = {9},
	doi = {10.1038/sj.npp.1300983},
	note = {PMID: 16319908},
	langid = {eng}
}

@article{barnas2005,
	title = {Treatment-Emergent Psychosis With Aripiprazole},
	author = {Barnas, Matthew E. and Hussain, Najeeb and Petrides, Georgios},
	year = {2005},
	month = {10},
	date = {2005-10-15},
	journal = {The Journal of Clinical Psychiatry},
	pages = {1339},
	volume = {66},
	number = {10},
	doi = {10.4088/JCP.v66n1019h},
	url = {http://article.psychiatrist.com/?ContentType=START&ID=10004775}
}

@article{raja2007,
	title = {Improvement or worsening of psychotic symptoms after treatment with low doses of aripiprazole},
	author = {Raja, Michele},
	year = {2007},
	month = {02},
	date = {2007-02},
	journal = {The International Journal of Neuropsychopharmacology},
	pages = {107},
	volume = {10},
	number = {01},
	doi = {10.1017/S1461145706006523},
	url = {https://academic.oup.com/ijnp/article-lookup/doi/10.1017/S1461145706006523},
	langid = {en}
}

@article{takeuchi2013,
	title = {A systematic review of reported cases involving psychotic symptoms worsened by aripiprazole in schizophrenia or schizoaffective disorder},
	author = {Takeuchi, Hiroyoshi and Remington, Gary},
	year = {2013},
	month = {07},
	date = {2013-07},
	journal = {Psychopharmacology},
	pages = {175--185},
	volume = {228},
	number = {2},
	doi = {10.1007/s00213-013-3154-1},
	url = {http://link.springer.com/10.1007/s00213-013-3154-1},
	langid = {en}
}

@article{takase2015,
	title = {Dopamine supersensitivity psychosis and dopamine partial agonist: A retrospective survey of failure of switching to aripiprazole in schizophrenia},
	author = {Takase, Masayuki and Kanahara, Nobuhisa and Oda, Yasunori and Kimura, Hiroshi and Watanabe, Hiroyuki and Iyo, Masaomi},
	year = {2015},
	month = {04},
	date = {2015-04},
	journal = {Journal of Psychopharmacology},
	pages = {383--389},
	volume = {29},
	number = {4},
	doi = {10.1177/0269881115570083},
	url = {http://journals.sagepub.com/doi/10.1177/0269881115570083},
	langid = {en}
}

@article{montastruc2019,
	title = {Association of Aripiprazole With the Risk for Psychiatric Hospitalization, Self-harm, or Suicide},
	author = {Montastruc, {François} and Nie, Rui and Loo, Simone and Rej, Soham and {Dell{\textquoteright}Aniello}, Sophie and Micallef, {Joëlle} and Suissa, Samy and Renoux, Christel},
	year = {2019},
	month = {04},
	date = {2019-04-01},
	journal = {JAMA Psychiatry},
	pages = {409},
	volume = {76},
	number = {4},
	doi = {10.1001/jamapsychiatry.2018.4149},
	url = {http://archpsyc.jamanetwork.com/article.aspx?doi=10.1001/jamapsychiatry.2018.4149},
	langid = {en}
}

@article{takeuchi2018,
	title = {Can Aripiprazole Worsen Psychosis in Schizophrenia?: A Meta-Analysis of Double-Blind, Randomized, Controlled Trials},
	author = {Takeuchi, Hiroyoshi and Fathi, Ali and Thiyanavadivel, Sadhana and Agid, Ofer and Remington, Gary},
	year = {2018},
	month = {04},
	date = {2018-04-25},
	journal = {The Journal of Clinical Psychiatry},
	pages = {17r11489},
	volume = {79},
	number = {2},
	doi = {10.4088/JCP.17r11489},
	url = {http://www.psychiatrist.com/JCP/article/Pages/2018/v79n02/17r11489.aspx}
}

@article{boileau2013,
	title = {The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride},
	author = {Boileau, Isabelle and Payer, Doris and Chugani, Bindiya and Lobo, Daniela and Behzadi, Arian and Rusjan, Pablo M. and Houle, Sylvain and Wilson, Alan A. and Warsh, Jerry and Kish, Stephen J. and Zack, Martin},
	year = {2013},
	month = {05},
	date = {2013-05},
	journal = {Addiction (Abingdon, England)},
	pages = {953--963},
	volume = {108},
	number = {5},
	doi = {10.1111/add.12066},
	note = {PMID: 23167711},
	langid = {eng}
}

@article{grallbronnec2016,
	title = {Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy: Do Patients Share the Same Features? A Review},
	author = {Grall-Bronnec, Marie and Sauvaget, Anne and Perrouin, Fanny and Leboucher, Juliette and Etcheverrigaray, {François} and Challet-Bouju, {Gaëlle} and Gaboriau, Louise and Derkinderen, Pascal and Jolliet, Pascale and Victorri-Vigneau, Caroline},
	year = {2016},
	month = {02},
	date = {2016-02},
	journal = {Journal of Clinical Psychopharmacology},
	pages = {63--70},
	volume = {36},
	number = {1},
	doi = {10.1097/JCP.0000000000000444},
	note = {PMID: 26658263
PMCID: PMC4700874},
	langid = {eng}
}

@article{maeda2014,
	title = {Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator},
	author = {Maeda, Kenji and Sugino, Haruhiko and Akazawa, Hitomi and Amada, Naoki and Shimada, Jun and Futamura, Takashi and Yamashita, Hiroshi and Ito, Nobuaki and McQuade, Robert D. and {Mørk}, Arne and Pehrson, Alan L. and Hentzer, Morten and Nielsen, Vibeke and Bundgaard, Christoffer and Arnt, {Jørn} and {Stensbøl}, Tine Bryan and Kikuchi, Tetsuro},
	year = {2014},
	month = {09},
	date = {2014-09},
	journal = {The Journal of Pharmacology and Experimental Therapeutics},
	pages = {589--604},
	volume = {350},
	number = {3},
	doi = {10.1124/jpet.114.213793},
	note = {PMID: 24947465},
	langid = {eng}
}

@article{das2016,
	title = {Brexpiprazole: so far so good},
	author = {Das, Saibal and Barnwal, Preeti and Winston A, Blessed and Mondal, Somnath and Saha, Indranil},
	year = {2016},
	month = {02},
	date = {2016-02},
	journal = {Therapeutic Advances in Psychopharmacology},
	pages = {39--54},
	volume = {6},
	number = {1},
	doi = {10.1177/2045125315614739},
	url = {http://journals.sagepub.com/doi/10.1177/2045125315614739},
	langid = {en}
}

@article{kishi2019,
	title = {Brexpiprazole as Adjunctive Treatment for Major Depressive Disorder Following Treatment Failure With at Least One Antidepressant in the Current Episode: a Systematic Review and Meta-Analysis},
	author = {Kishi, Taro and Sakuma, Kenji and Nomura, Ikuo and Matsuda, Yuki and Mishima, Kazuo and Iwata, Nakao},
	year = {2019},
	month = {11},
	date = {2019-11-01},
	journal = {The International Journal of Neuropsychopharmacology},
	pages = {698--709},
	volume = {22},
	number = {11},
	doi = {10.1093/ijnp/pyz040},
	note = {PMID: 31350882
PMCID: PMC6872963},
	langid = {eng}
}

@article{correll2015,
	title = {Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial},
	author = {Correll, Christoph U. and Skuban, Aleksandar and Ouyang, John and Hobart, Mary and Pfister, Stephanie and McQuade, Robert D. and Nyilas, Margaretta and Carson, William H. and Sanchez, Raymond and Eriksson, Hans},
	year = {2015},
	month = {09},
	date = {2015-09-01},
	journal = {The American Journal of Psychiatry},
	pages = {870--880},
	volume = {172},
	number = {9},
	doi = {10.1176/appi.ajp.2015.14101275},
	note = {PMID: 25882325},
	langid = {eng}
}

@article{kane2015,
	title = {A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia},
	author = {Kane, John M. and Skuban, Aleksandar and Ouyang, John and Hobart, Mary and Pfister, Stephanie and McQuade, Robert D. and Nyilas, Margaretta and Carson, William H. and Sanchez, Raymond and Eriksson, Hans},
	year = {2015},
	month = {05},
	date = {2015-05},
	journal = {Schizophrenia Research},
	pages = {127--135},
	volume = {164},
	number = {1-3},
	doi = {10.1016/j.schres.2015.01.038},
	note = {PMID: 25682550},
	langid = {eng}
}

@article{fleischhacker2017,
	title = {Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study},
	author = {Fleischhacker, W. Wolfgang and Hobart, Mary and Ouyang, John and Forbes, Andy and Pfister, Stephanie and McQuade, Robert D. and Carson, William H. and Sanchez, Raymond and Nyilas, Margareta and Weiller, Emmanuelle},
	year = {2017},
	month = {01},
	date = {2017-01-01},
	journal = {The International Journal of Neuropsychopharmacology},
	pages = {11--21},
	volume = {20},
	number = {1},
	doi = {10.1093/ijnp/pyw076},
	note = {PMID: 27566723
PMCID: PMC5412583},
	langid = {eng}
}

@article{forbes2018,
	title = {A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults with Schizophrenia},
	author = {Forbes, Andy and Hobart, Mary and Ouyang, John and Shi, Lily and Pfister, Stephanie and Hakala, Mika},
	year = {2018},
	month = {05},
	date = {2018-05-01},
	journal = {The International Journal of Neuropsychopharmacology},
	pages = {433--441},
	volume = {21},
	number = {5},
	doi = {10.1093/ijnp/pyy002},
	note = {PMID: 29415258
PMCID: PMC5932477},
	langid = {eng}
}

@article{thase2015,
	title = {Efficacy and safety of adjunctive brexpiprazole 2 mg in major depressive disorder: a phase 3, randomized, placebo-controlled study in patients with inadequate response to antidepressants},
	author = {Thase, Michael E. and Youakim, James M. and Skuban, Aleksandar and Hobart, Mary and Augustine, Carole and Zhang, Peter and McQuade, Robert D. and Carson, William H. and Nyilas, Margaretta and Sanchez, Raymond and Eriksson, Hans},
	year = {2015},
	month = {09},
	date = {2015-09},
	journal = {The Journal of Clinical Psychiatry},
	pages = {1224--1231},
	volume = {76},
	number = {9},
	doi = {10.4088/JCP.14m09688},
	note = {PMID: 26301701},
	langid = {eng}
}


@article{thase_adjunctive_2015,
	title = {Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study},
	volume = {76},
	issn = {1555-2101},
	shorttitle = {Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants},
	doi = {10.4088/JCP.14m09689},
	language = {eng},
	number = {9},
	journal = {The Journal of Clinical Psychiatry},
	author = {Thase, Michael E. and Youakim, James M. and Skuban, Aleksandar and Hobart, Mary and Zhang, Peter and McQuade, Robert D. and Nyilas, Margaretta and Carson, William H. and Sanchez, Raymond and Eriksson, Hans},
	month = sep,
	year = {2015},
	pmid = {26301771},
	keywords = {Adolescent, Adult, Aged, Antidepressive Agents, Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant, Dose-Response Relationship, Drug, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Quinolones, Thiophenes, Treatment Outcome, Young Adult},
	pages = {1232--1240},
}

@article{hobart2018,
	title = {A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Fixed-Dose Brexpiprazole 2 mg/d as Adjunctive Treatment of Adults With Major Depressive Disorder},
	author = {Hobart, Mary and Skuban, Aleksandar and Zhang, Peter and Augustine, Carole and Brewer, Claudette and Hefting, Nanco and Sanchez, Raymond and McQuade, Robert D.},
	year = {2018},
	month = {05},
	date = {2018-05-22},
	journal = {The Journal of Clinical Psychiatry},
	pages = {17m12058},
	volume = {79},
	number = {4},
	doi = {10.4088/JCP.17m12058},
	note = {PMID: 29873953},
	langid = {eng}
}


@article{hobart_efficacy_2018,
	title = {Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study},
	volume = {34},
	issn = {1473-4877},
	shorttitle = {Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder},
	doi = {10.1080/03007995.2018.1430220},
	language = {eng},
	number = {4},
	journal = {Current Medical Research and Opinion},
	author = {Hobart, Mary and Skuban, Aleksandar and Zhang, Peter and Josiassen, Mette Krog and Hefting, Nanco and Augustine, Carole and Brewer, Claudette and Sanchez, Raymond and McQuade, Robert D.},
	month = apr,
	year = {2018},
	pmid = {29343128},
	keywords = {adjunctive, Adult, antidepressant, Antidepressive Agents, Brexpiprazole, clinical trial, Depressive Disorder, Major, Double-Blind Method, Drug Therapy, Combination, Female, Headache, Humans, major depressive disorder, Male, Middle Aged, Prospective Studies, Psychomotor Agitation, Quetiapine Fumarate, Quinolones, Thiophenes, Treatment Outcome},
	pages = {633--642},
	file = {Full Text:C\:\\Users\\Ansel\\Zotero\\storage\\3JZ92MNQ\\Hobart et al. - 2018 - Efficacy and safety of flexibly dosed brexpiprazol.pdf:application/pdf},
}

@article{watanabe2020,
	title = {Brexpiprazole for the Treatment of Schizophrenia in Adults: An Overview of Its Clinical Efficacy and Safety and a Psychiatrist's Perspective},
	author = {Watanabe, Yoshinori and Yamada, Sakiko and Otsubo, Tempei and Kikuchi, Toshiaki},
	year = {2020},
	date = {2020},
	journal = {Drug Design, Development and Therapy},
	pages = {5559--5574},
	volume = {14},
	doi = {10.2147/DDDT.S240859},
	note = {PMID: 33376301
PMCID: PMC7755340},
	langid = {eng}
}

@article{citrome2016,
	title = {The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia: results from a randomized, exploratory study},
	author = {Citrome, Leslie and Ota, Ai and Nagamizu, Kazuhiro and Perry, Pamela and Weiller, Emmanuelle and Baker, Ross A.},
	year = {2016},
	month = {07},
	date = {2016-07},
	journal = {International Clinical Psychopharmacology},
	pages = {192--201},
	volume = {31},
	number = {4},
	doi = {10.1097/YIC.0000000000000123},
	note = {PMID: 26963842},
	langid = {eng}
}

@article{kishi2020,
	title = {Aripiprazole vs. brexpiprazole for acute schizophrenia: a systematic review and network meta-analysis},
	author = {Kishi, Taro and Ikuta, Toshikazu and Matsuda, Yuki and Sakuma, Kenji and Iwata, Nakao},
	year = {2020},
	month = {05},
	date = {2020-05},
	journal = {Psychopharmacology},
	pages = {1459--1470},
	volume = {237},
	number = {5},
	doi = {10.1007/s00213-020-05472-5},
	url = {http://link.springer.com/10.1007/s00213-020-05472-5},
	langid = {en}
}

@article{tarazi2012,
	title = {Iloperidone, asenapine and lurasidone: a primer on their current status},
	author = {Tarazi, Frank I. and Stahl, Stephen M.},
	year = {2012},
	month = {09},
	date = {2012-09},
	journal = {Expert Opinion on Pharmacotherapy},
	pages = {1911--1922},
	volume = {13},
	number = {13},
	doi = {10.1517/14656566.2012.712114},
	note = {PMID: 22849428},
	langid = {eng}
}

@article{kongsamut1996,
	title = {Iloperidone binding to human and rat dopamine and 5-HT receptors},
	author = {Kongsamut, S. and Roehr, J. E. and Cai, J. and Hartman, H. B. and Weissensee, P. and Kerman, L. L. and Tang, L. and Sandrasagra, A.},
	year = {1996},
	month = {12},
	date = {1996-12-19},
	journal = {European Journal of Pharmacology},
	pages = {417--423},
	volume = {317},
	number = {2-3},
	doi = {10.1016/s0014-2999(96)00840-0},
	note = {PMID: 8997630},
	langid = {eng}
}

@article{cutler2008,
	title = {Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia},
	author = {Cutler, Andrew J. and Kalali, Amir H. and Weiden, Peter J. and Hamilton, Jennifer and Wolfgang, Curt D.},
	year = {2008},
	month = {04},
	date = {2008-04},
	journal = {Journal of Clinical Psychopharmacology},
	pages = {S20--28},
	volume = {28},
	number = {2 Suppl 1},
	doi = {10.1097/JCP.0b013e318169d4ce},
	note = {PMID: 18334909},
	langid = {eng}
}

@article{potkin2008,
	title = {Efficacy of iloperidone in the treatment of schizophrenia: initial phase 3 studies},
	author = {Potkin, Steven G. and Litman, Robert E. and Torres, Rosarelis and Wolfgang, Curt D.},
	year = {2008},
	month = {04},
	date = {2008-04},
	journal = {Journal of Clinical Psychopharmacology},
	pages = {S4--11},
	volume = {28},
	number = {2 Suppl 1},
	doi = {10.1097/JCP.0b013e3181692787},
	note = {PMID: 18334911},
	langid = {eng}
}

@article{weiden2016,
	title = {A Randomized Trial of Iloperidone for Prevention of Relapse in Schizophrenia: The REPRIEVE Study},
	author = {Weiden, Peter J. and Manning, Raymond and Wolfgang, Curt D. and Ryan, J. Michael and Mancione, Linda and Han, Guangyang and Ahmed, Saeed and Mayo, Mallery G.},
	year = {2016},
	month = {08},
	date = {2016-08},
	journal = {CNS drugs},
	pages = {735--747},
	volume = {30},
	number = {8},
	doi = {10.1007/s40263-016-0345-4},
	note = {PMID: 27379654
PMCID: PMC4982888},
	langid = {eng}
}

@article{peuskens2014,
	title = {The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review},
	author = {Peuskens, J. and Pani, L. and Detraux, J. and De Hert, M.},
	year = {2014},
	month = {05},
	date = {2014-05},
	journal = {CNS drugs},
	pages = {421--453},
	volume = {28},
	number = {5},
	doi = {10.1007/s40263-014-0157-3},
	note = {PMID: 24677189
PMCID: PMC4022988},
	langid = {eng}
}

@article{freeman2013,
	title = {Iloperidone-induced retrograde ejaculation},
	author = {Freeman, Scott A.},
	year = {2013},
	month = {05},
	date = {2013-05},
	journal = {International Clinical Psychopharmacology},
	pages = {156},
	volume = {28},
	number = {3},
	doi = {10.1097/YIC.0b013e32835e9112},
	note = {PMID: 23385360},
	langid = {eng}
}

@article{latorre2013,
	title = {Sexual dysfunction related to psychotropic drugs: a critical review part II: antipsychotics},
	author = {La Torre, A. and Conca, A. and Duffy, D. and Giupponi, G. and Pompili, M. and {Grözinger}, M.},
	year = {2013},
	month = {09},
	date = {2013-09},
	journal = {Pharmacopsychiatry},
	pages = {201--208},
	volume = {46},
	number = {6},
	doi = {10.1055/s-0033-1347177},
	note = {PMID: 23737244},
	langid = {eng}
}

@article{potkin2013,
	title = {A Thorough QTc Study of 3 Doses of Iloperidone Including Metabolic Inhibition Via CYP2D6 and/or CYP3A4 and a Comparison to Quetiapine and Ziprasidone},
	author = {Potkin, Steven G. and Preskorn, Sheldon and Hochfeld, Marla and Meng, Xiangyi},
	year = {2013},
	month = {02},
	date = {2013-02},
	journal = {Journal of Clinical Psychopharmacology},
	pages = {3--10},
	volume = {33},
	number = {1},
	doi = {10.1097/JCP.0b013e31827c0314},
	url = {https://journals.lww.com/00004714-201302000-00002},
	langid = {en}
}

@article{lavedan2008,
	title = {Effect of a ciliary neurotrophic factor polymorphism on schizophrenia symptom improvement in an iloperidone clinical trial},
	author = {Lavedan, Christian and Volpi, Simona and Polymeropoulos, Mihael H. and Wolfgang, Curt D.},
	year = {2008},
	month = {03},
	date = {2008-03},
	journal = {Pharmacogenomics},
	pages = {289--301},
	volume = {9},
	number = {3},
	doi = {10.2217/14622416.9.3.289},
	note = {PMID: 18303965},
	langid = {eng}
}

@article{weiden2012,
	title = {Iloperidone for the treatment of schizophrenia: an updated clinical review},
	author = {Weiden, Peter J.},
	year = {2012},
	month = {04},
	date = {2012-04},
	journal = {Clinical Schizophrenia & Related Psychoses},
	pages = {34--44},
	volume = {6},
	number = {1},
	doi = {10.3371/CSRP.6.1.5},
	note = {PMID: 22453868},
	langid = {eng}
}

@article{citrome2014,
	title = {Asenapine review, part I: chemistry, receptor affinity profile, pharmacokinetics and metabolism},
	author = {Citrome, Leslie},
	year = {2014},
	month = {06},
	date = {2014-06},
	journal = {Expert Opinion on Drug Metabolism & Toxicology},
	pages = {893--903},
	volume = {10},
	number = {6},
	doi = {10.1517/17425255.2014.908185},
	note = {PMID: 24793403},
	langid = {eng}
}


@article{citrome_asenapine_2009,
	title = {Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic},
	volume = {63},
	issn = {1742-1241},
	shorttitle = {Asenapine for schizophrenia and bipolar disorder},
	doi = {10.1111/j.1742-1241.2009.02228.x},
	language = {eng},
	number = {12},
	journal = {International Journal of Clinical Practice},
	author = {Citrome, L.},
	month = dec,
	year = {2009},
	pmid = {19840150},
	keywords = {Administration, Sublingual, Antipsychotic Agents, Bipolar Disorder, Cytochrome P-450 Enzyme System, Dibenzocycloheptenes, Heterocyclic Compounds, 4 or More Rings, Humans, Randomized Controlled Trials as Topic, Schizophrenia, Treatment Outcome},
	pages = {1762--1784},
	file = {Full Text:C\:\\Users\\Ansel\\Zotero\\storage\\MEBEULMI\\Citrome - 2009 - Asenapine for schizophrenia and bipolar disorder .pdf:application/pdf},
}


@article{citrome_asenapine_2014,
	title = {Asenapine review, part {II}: clinical efficacy, safety and tolerability},
	issn = {1474-0338, 1744-764X},
	shorttitle = {Asenapine review, part {II}},
	url = {http://www.tandfonline.com/doi/full/10.1517/14740338.2014.908183},
	doi = {10.1517/14740338.2014.908183},
	language = {en},
	urldate = {2022-04-30},
	journal = {Expert Opinion on Drug Safety},
	author = {Citrome, Leslie},
	month = may,
	year = {2014},
	pages = {1--28},
}

@article{mccall2014,
	title = {Asenapine-induced restless legs syndrome: differentiation from akathisia},
	author = {McCall, W. Vaughn and Riley, Mary Anne and Hodges, Chelsea and McCloud, Laryssa and Phillips, Marjorie and Rosenquist, Peter B.},
	year = {2014},
	month = {12},
	date = {2014-12-15},
	journal = {Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine},
	pages = {1341--1342},
	volume = {10},
	number = {12},
	doi = {10.5664/jcsm.4296},
	note = {PMID: 25325577
PMCID: PMC4237529},
	langid = {eng}
}

@article{schoemaker2012,
	title = {Long-term efficacy and safety of asenapine or olanzapine in patients with schizophrenia or schizoaffective disorder: an extension study},
	author = {Schoemaker, J. and Stet, L. and Vrijland, P. and Naber, D. and Panagides, J. and Emsley, R.},
	year = {2012},
	month = {07},
	date = {2012-07},
	journal = {Pharmacopsychiatry},
	pages = {196--203},
	volume = {45},
	number = {5},
	doi = {10.1055/s-0031-1301310},
	note = {PMID: 22454251},
	langid = {eng}
}

@article{citrome2020,
	title = {Efficacy and Safety of HP-3070, an Asenapine Transdermal System, in Patients With Schizophrenia: A Phase 3, Randomized, Placebo-Controlled Study},
	author = {Citrome, Leslie and Walling, David P. and Zeni, Courtney M. and Starling, Brittney R. and Terahara, Takaaki and Kuriki, Masaaki and Park, Alexandra S. and Komaroff, Marina},
	year = {2020},
	month = {12},
	date = {2020-12-15},
	journal = {The Journal of Clinical Psychiatry},
	pages = {20m13602},
	volume = {82},
	number = {1},
	doi = {10.4088/JCP.20m13602},
	note = {PMID: 33326711},
	langid = {eng}
}

@article{javed2019,
	title = {Practical Guidance on the Use of Lurasidone for the Treatment of Adults with Schizophrenia},
	author = {Javed, Afzal and Arthur, Holger and Curtis, Logos and Hansen, Lars and Pappa, Sofia},
	year = {2019},
	month = {12},
	date = {2019-12},
	journal = {Neurology and Therapy},
	pages = {215--230},
	volume = {8},
	number = {2},
	doi = {10.1007/s40120-019-0138-z},
	note = {PMID: 31098889
PMCID: PMC6858892},
	langid = {eng}
}

@article{inamdar2015,
	title = {Long-term Lurasidone Treatment is Not Associated with Clinically Significant Elevations of Prolactin- or Hyperprolactinaemia-related Adverse Events: a Post-HOC Analysis},
	author = {Inamdar, A. and Dunlop, J. and Palma dos Reis, R. and Andersson, H. and Murthy, V.},
	year = {2015},
	month = {03},
	date = {2015-03},
	journal = {European Psychiatry},
	pages = {1723},
	volume = {30},
	doi = {10.1016/S0924-9338(15)31323-7},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0924933815313237},
	langid = {en}
}

@article{zhang2017,
	title = {The metabolic side effects of 12 antipsychotic drugs used for the treatment of schizophrenia on glucose: a network meta-analysis},
	author = {Zhang, Yangyu and Liu, Yingyu and Su, Yingying and You, Yueyue and Ma, Yue and Yang, Guang and Song, Yan and Liu, Xinyu and Wang, Mohan and Zhang, Lili and Kou, Changgui},
	year = {2017},
	month = {12},
	date = {2017-12},
	journal = {BMC Psychiatry},
	pages = {373},
	volume = {17},
	number = {1},
	doi = {10.1186/s12888-017-1539-0},
	url = {https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-017-1539-0},
	langid = {en}
}

@article{clayton2018,
	title = {Effect of Lurasidone on Sexual Function in Major Depressive Disorder Patients With Subthreshold Hypomanic Symptoms (Mixed Features): Results From a Placebo-Controlled Trial},
	author = {Clayton, Anita H. and Tsai, Joyce and Mao, Yongcai and Pikalov, Andrei and Loebel, Antony},
	year = {2018},
	month = {08},
	date = {2018-08-07},
	journal = {The Journal of Clinical Psychiatry},
	pages = {18m12132},
	volume = {79},
	number = {5},
	doi = {10.4088/JCP.18m12132},
	note = {PMID: 30086213},
	langid = {eng}
}

@article{loebel2013,
	title = {Efficacy and safety of lurasidone 80mg/day and 160mg/day in the treatment of schizophrenia: A randomized, double-blind, placebo- and active-controlled trial},
	author = {Loebel, Antony and Cucchiaro, Josephine and Sarma, Kaushik and Xu, Lei and Hsu, Chuanchieh and Kalali, Amir H. and Pikalov, Andrei and Potkin, Steven G.},
	year = {2013},
	month = {04},
	date = {2013-04},
	journal = {Schizophrenia Research},
	pages = {101--109},
	volume = {145},
	number = {1-3},
	doi = {10.1016/j.schres.2013.01.009},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0920996413000479},
	langid = {en}
}

@article{citrome2017,
	title = {Activating and Sedating Adverse Effects of Second-Generation Antipsychotics in the Treatment of Schizophrenia and Major Depressive Disorder: Absolute Risk Increase and Number Needed to Harm},
	author = {Citrome, Leslie},
	year = {2017},
	month = {04},
	date = {2017-04},
	journal = {Journal of Clinical Psychopharmacology},
	pages = {138--147},
	volume = {37},
	number = {2},
	doi = {10.1097/JCP.0000000000000665},
	note = {PMID: 28141623},
	langid = {eng}
}

@article{westrich2015,
	title = {Involvement of 5-HT₇ receptors in vortioxetine's modulation of circadian rhythms and episodic memory in rodents},
	author = {Westrich, Ligia and Haddjeri, Nasser and Dkhissi-Benyahya, Ouria and {Sánchez}, Connie},
	year = {2015},
	month = {02},
	date = {2015-02},
	journal = {Neuropharmacology},
	pages = {382--390},
	volume = {89},
	doi = {10.1016/j.neuropharm.2014.10.015},
	note = {PMID: 25446573},
	langid = {eng}
}

@article{huang2012,
	title = {5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux},
	author = {Huang, Mei and Horiguchi, Masakuni and Felix, Anna R. and Meltzer, Herbert Y.},
	year = {2012},
	month = {05},
	date = {2012-05-09},
	journal = {Neuroreport},
	pages = {436--440},
	volume = {23},
	number = {7},
	doi = {10.1097/WNR.0b013e328352de40},
	note = {PMID: 22415605},
	langid = {eng}
}

@article{horisawa2013,
	title = {The role of 5-HT7 receptor antagonism in the amelioration of MK-801-induced learning and memory deficits by the novel atypical antipsychotic drug lurasidone},
	author = {Horisawa, Tomoko and Nishikawa, Hiroyuki and Toma, Satoko and Ikeda, Atsushi and Horiguchi, Masakuni and Ono, Michiko and Ishiyama, Takeo and Taiji, Mutsuo},
	year = {2013},
	month = {05},
	date = {2013-05-01},
	journal = {Behavioural Brain Research},
	pages = {66--69},
	volume = {244},
	doi = {10.1016/j.bbr.2013.01.026},
	note = {PMID: 23376699},
	langid = {eng}
}

@article{yuksel2019,
	title = {Protective effect of 5-HT7 receptor activation against glutamate-induced neurotoxicity in human neuroblastoma SH-SY5Y cells via antioxidative and antiapoptotic pathways},
	author = {Yuksel, Tugba Nurcan and Yayla, Muhammed and Halici, Zekai and Cadirci, Elif and Polat, Beyzagul and Kose, Duygu},
	year = {2019},
	month = {03},
	date = {2019-03},
	journal = {Neurotoxicology and Teratology},
	pages = {22--28},
	volume = {72},
	doi = {10.1016/j.ntt.2019.01.002},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0892036218300576},
	langid = {en}
}

@article{meneses2015,
	title = {5-HT7 receptor activation: procognitive and antiamnesic effects},
	author = {Meneses, A. and Perez-Garcia, G. and Liy-Salmeron, G. and {Ponce-López}, T. and Lacivita, E. and Leopoldo, M.},
	year = {2015},
	month = {02},
	date = {2015-02},
	journal = {Psychopharmacology},
	pages = {595--603},
	volume = {232},
	number = {3},
	doi = {10.1007/s00213-014-3693-0},
	note = {PMID: 25074446},
	langid = {eng}
}

@article{meneses2014,
	title = {5-HT7 receptor stimulation and blockade: a therapeutic paradox about memory formation and amnesia},
	author = {Meneses, Alfredo},
	year = {2014},
	date = {2014},
	journal = {Frontiers in Behavioral Neuroscience},
	pages = {207},
	volume = {8},
	doi = {10.3389/fnbeh.2014.00207},
	note = {PMID: 24971055
PMCID: PMC4053683},
	langid = {eng}
}

@article{meltzer2020,
	title = {Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia},
	author = {Meltzer, Herbert Y. and Share, Daniel B. and Jayathilake, Karu and Salomon, Ronald M. and Lee, Myung A.},
	year = {2020},
	month = {05},
	date = {2020-05},
	journal = {Journal of Clinical Psychopharmacology},
	pages = {240--249},
	volume = {40},
	number = {3},
	doi = {10.1097/JCP.0000000000001205},
	url = {https://journals.lww.com/10.1097/JCP.0000000000001205},
	langid = {en}
}

@article{nikiforuk2015,
	title = {Targeting the Serotonin 5-HT7 Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date},
	author = {Nikiforuk, Agnieszka},
	year = {2015},
	month = {04},
	date = {2015-04},
	journal = {CNS drugs},
	pages = {265--275},
	volume = {29},
	number = {4},
	doi = {10.1007/s40263-015-0236-0},
	note = {PMID: 25721336
PMCID: PMC4555343},
	langid = {eng}
}

@article{stahl2016,
	title = {Mechanism of action of cariprazine},
	author = {Stahl, Stephen M.},
	year = {2016},
	month = {04},
	date = {2016-04},
	journal = {CNS Spectrums},
	pages = {123--127},
	volume = {21},
	number = {2},
	doi = {10.1017/S1092852916000043},
	url = {https://www.cambridge.org/core/product/identifier/S1092852916000043/type/journal_article},
	langid = {en}
}

@article{kiss2019,
	title = {Preclinical pharmacodynamic and pharmacokinetic characterization of the major metabolites of cariprazine},
	author = {Kiss, {Béla} and {Némethy}, Zsolt and Fazekas, {Károly} and {Kurkó}, Dalma and {Gyertyán}, {István} and {Sághy}, Katalin and Laszlovszky, {István} and Farkas, Bence and Kirschner, Norbert and {Bolf-Terjéki}, Etelka and {Balázs}, Ottilia and Lendvai, {Balázs}},
	year = {2019},
	date = {2019},
	journal = {Drug Design, Development and Therapy},
	pages = {3229--3248},
	volume = {13},
	doi = {10.2147/DDDT.S188760},
	note = {PMID: 31571826
PMCID: PMC6754336},
	langid = {eng}
}


@article{kane_efficacy_2015,
	title = {Efficacy and {Safety} of {Cariprazine} in {Acute} {Exacerbation} of {Schizophrenia}: {Results} {From} an {International}, {Phase} {III} {Clinical} {Trial}},
	volume = {35},
	issn = {0271-0749},
	shorttitle = {Efficacy and {Safety} of {Cariprazine} in {Acute} {Exacerbation} of {Schizophrenia}},
	url = {https://journals.lww.com/00004714-201508000-00003},
	doi = {10.1097/JCP.0000000000000346},
	language = {en},
	number = {4},
	urldate = {2022-04-30},
	journal = {Journal of Clinical Psychopharmacology},
	author = {Kane, John M. and Zukin, Stephen and Wang, Yao and Lu, Kaifeng and Ruth, Adam and Nagy, Krisztián and Laszlovszky, István and Durgam, Suresh},
	month = aug,
	year = {2015},
	pages = {367--373},
}

@article{durgam2015,
	title = {Cariprazine in Acute Exacerbation of Schizophrenia: A Fixed-Dose, Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Trial},
	author = {Durgam, Suresh and Cutler, Andrew J. and Lu, Kaifeng and Migliore, Raffaele and Ruth, Adam and Laszlovszky, {István} and {Németh}, {György} and Meltzer, Herbert Y.},
	year = {2015},
	month = {12},
	date = {2015-12-23},
	journal = {The Journal of Clinical Psychiatry},
	pages = {e1574--e1582},
	volume = {76},
	number = {12},
	doi = {10.4088/JCP.15m09997},
	url = {http://www.psychiatrist.com/jcp/article/pages/2015/v76n12/v76n1201.aspx}
}

@article{durgam2016,
	title = {Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial},
	author = {Durgam, Suresh and Earley, Willie and Li, Rui and Li, Dayong and Lu, Kaifeng and Laszlovszky, {István} and Fleischhacker, W. Wolfgang and Nasrallah, Henry A.},
	year = {2016},
	month = {10},
	date = {2016-10},
	journal = {Schizophrenia Research},
	pages = {264--271},
	volume = {176},
	number = {2-3},
	doi = {10.1016/j.schres.2016.06.030},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0920996416303127},
	langid = {en}
}


@article{durgam_efficacy_2015,
	title = {The efficacy and tolerability of cariprazine in acute mania associated with bipolar {I} disorder: a phase {II} trial},
	volume = {17},
	issn = {1398-5647, 1399-5618},
	shorttitle = {The efficacy and tolerability of cariprazine in acute mania associated with bipolar {I} disorder},
	url = {https://onlinelibrary.wiley.com/doi/10.1111/bdi.12238},
	doi = {10.1111/bdi.12238},
	language = {en},
	number = {1},
	urldate = {2022-04-30},
	journal = {Bipolar Disorders},
	author = {Durgam, Suresh and Starace, Anju and Li, Dayong and Migliore, Raffaele and Ruth, Adam and Németh, György and Laszlovszky, István},
	month = feb,
	year = {2015},
	pages = {63--75},
	file = {Full Text:C\:\\Users\\Ansel\\Zotero\\storage\\GJU9YB8P\\Durgam et al. - 2015 - The efficacy and tolerability of cariprazine in ac.pdf:application/pdf},
}

@article{sachs2015,
	title = {Cariprazine in the treatment of acute mania in bipolar I disorder: A double-blind, placebo-controlled, Phase III trial},
	author = {Sachs, Gary S. and Greenberg, William M. and Starace, Anju and Lu, Kaifeng and Ruth, Adam and Laszlovszky, {István} and {Németh}, {György} and Durgam, Suresh},
	year = {2015},
	month = {03},
	date = {2015-03},
	journal = {Journal of Affective Disorders},
	pages = {296--302},
	volume = {174},
	doi = {10.1016/j.jad.2014.11.018},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0165032714007289},
	langid = {en}
}

@article{calabrese2015,
	title = {Efficacy and Safety of Low- and High-Dose Cariprazine in Acute and Mixed Mania Associated With Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study},
	author = {Calabrese, Joseph R. and {Keck, Jr}, Paul E. and Starace, Anju and Lu, Kaifeng and Ruth, Adam and Laszlovszky, {István} and {Németh}, {György} and Durgam, Suresh},
	year = {2015},
	month = {03},
	date = {2015-03-25},
	journal = {The Journal of Clinical Psychiatry},
	pages = {284--292},
	volume = {76},
	number = {03},
	doi = {10.4088/JCP.14m09081},
	url = {http://www.psychiatrist.com/jcp/article/pages/2015/v76n03/v76n0306.aspx}
}


@article{durgam_depression_2016,
	title = {An 8-{Week} {Randomized}, {Double}-{Blind}, {Placebo}-{Controlled} {Evaluation} of the {Safety} and {Efficacy} of {Cariprazine} in {Patients} {With} {Bipolar} {I} {Depression}},
	volume = {173},
	issn = {1535-7228},
	doi = {10.1176/appi.ajp.2015.15020164},
	language = {eng},
	number = {3},
	journal = {The American Journal of Psychiatry},
	author = {Durgam, Suresh and Earley, Willie and Lipschitz, Alan and Guo, Hua and Laszlovszky, István and Németh, György and Vieta, Eduard and Calabrese, Joseph R. and Yatham, Lakshmi N.},
	month = mar,
	year = {2016},
	pmid = {26541814},
	keywords = {Adult, Antipsychotic Agents, Bipolar Disorder, Depression, Dose-Response Relationship, Drug, Double-Blind Method, Drug Monitoring, Female, Humans, Male, Middle Aged, Piperazines, Psychiatric Status Rating Scales, Treatment Outcome},
	pages = {271--281},
	file = {Full Text:C\:\\Users\\Ansel\\Zotero\\storage\\RKL7L5S7\\Durgam et al. - 2016 - An 8-Week Randomized, Double-Blind, Placebo-Contro.pdf:application/pdf},
}


@article{durgam_adjunctive_2016,
	title = {Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder},
	volume = {77},
	issn = {1555-2101},
	shorttitle = {Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants},
	doi = {10.4088/JCP.15m10070},
	language = {eng},
	number = {3},
	journal = {The Journal of Clinical Psychiatry},
	author = {Durgam, Suresh and Earley, Willie and Guo, Hua and Li, Dayong and Németh, György and Laszlovszky, István and Fava, Maurizio and Montgomery, Stuart A.},
	month = mar,
	year = {2016},
	pmid = {27046309},
	keywords = {Adolescent, Adult, Aged, Antidepressive Agents, Antipsychotic Agents, Depressive Disorder, Major, Dose-Response Relationship, Drug, Double-Blind Method, Drug Resistance, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Piperazines, Young Adult},
	pages = {371--378},
}

@article{lao2016,
	title = {Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled Trials},
	author = {Lao, Kim S. J. and He, Ying and Wong, Ian C. K. and Besag, Frank M. C. and Chan, Esther W.},
	year = {2016},
	month = {11},
	date = {2016-11},
	journal = {CNS drugs},
	pages = {1043--1054},
	volume = {30},
	number = {11},
	doi = {10.1007/s40263-016-0382-z},
	note = {PMID: 27550371},
	langid = {eng}
}

@article{snyder2015,
	title = {Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission},
	author = {Snyder, Gretchen L. and Vanover, Kimberly E. and Zhu, Hongwen and Miller, Diane B. and {O'Callaghan}, James P. and Tomesch, John and Li, Peng and Zhang, Qiang and Krishnan, Vaishnav and Hendrick, Joseph P. and Nestler, Eric J. and Davis, Robert E. and Wennogle, Lawrence P. and Mates, Sharon},
	year = {2015},
	month = {02},
	date = {2015-02},
	journal = {Psychopharmacology},
	pages = {605--621},
	volume = {232},
	number = {3},
	doi = {10.1007/s00213-014-3704-1},
	note = {PMID: 25120104
PMCID: PMC4302236},
	langid = {eng}
}

@article{vanover2019,
	title = {Dopamine D2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia},
	author = {Vanover, Kimberly E. and Davis, Robert E. and Zhou, Yun and Ye, Weiguo and {Bra{\v{s}}i{\'{c}}}, James R. and Gapasin, Lorena and Saillard, Jelena and Weingart, Michal and Litman, Robert E. and Mates, Sharon and Wong, Dean F.},
	year = {2019},
	month = {02},
	date = {2019-02},
	journal = {Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology},
	pages = {598--605},
	volume = {44},
	number = {3},
	doi = {10.1038/s41386-018-0251-1},
	note = {PMID: 30449883
PMCID: PMC6333832},
	langid = {eng}
}

@article{zhang2018,
	title = {The presynaptic D2 partial agonist lumateperone acts as a postsynaptic D2 antagonist},
	author = {Zhang, Lei and Hendrick, Joseph},
	year = {2018},
	month = {03},
	date = {2018-03-12},
	journal = {Matters},
	doi = {10.19185/matters.201712000006},
	url = {https://sciencematters.io/articles/10.19185/matters.201712000006},
	langid = {en}
}

@article{kumar2018,
	title = {Lumateperone: a new treatment approach for neuropsychiatric disorders},
	author = {Kumar, B. and Kuhad, A. and Kuhad, A.},
	year = {2018},
	month = {12},
	date = {2018-12},
	journal = {Drugs of Today (Barcelona, Spain: 1998)},
	pages = {713--719},
	volume = {54},
	number = {12},
	doi = {10.1358/dot.2018.54.12.2899443},
	note = {PMID: 30596390},
	langid = {eng}
}

@article{snyder2018,
	title = {Unique Pharmacology and Clinical Evidence Supporting the Antidepressant Therapeutic Potential of Lumateperone},
	author = {Snyder, Gretchen and Davis, Robert and Dutheil, Sophie and Hendrick, Joseph and Zhang, Lei and Wennogle, Lawrence and Satlin, Andrew and Marcus, Monica and Mates, Sharon and Vanover, Kim and Svensson, Torgny},
	year = {2018},
	month = {05},
	date = {2018-05},
	journal = {Biological Psychiatry},
	pages = {S378},
	volume = {83},
	number = {9},
	doi = {10.1016/j.biopsych.2018.02.972},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0006322318310746},
	langid = {en}
}

@article{davis2015,
	title = {ITI-007 demonstrates brain occupancy at serotonin 5-HT₂A and dopamine D₂ receptors and serotonin transporters using positron emission tomography in healthy volunteers},
	author = {Davis, Robert E. and Vanover, Kimberly E. and Zhou, Yun and {Bra{\v{s}}i{\'{c}}}, James R. and Guevara, Maria and Bisuna, Blanca and Ye, Weiguo and Raymont, Vanessa and Willis, William and Kumar, Anil and Gapasin, Lorena and Goldwater, D. Ronald and Mates, Sharon and Wong, Dean F.},
	year = {2015},
	month = {08},
	date = {2015-08},
	journal = {Psychopharmacology},
	pages = {2863--2872},
	volume = {232},
	number = {15},
	doi = {10.1007/s00213-015-3922-1},
	note = {PMID: 25843749},
	langid = {eng}
}

@article{meltzer2012,
	title = {Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2mg/day, but does not enhance efficacy of haloperidol, 2mg/day: comparison with reference dose risperidone, 6mg/day},
	author = {Meltzer, Herbert Y. and Elkis, Helio and Vanover, Kimberly and Weiner, David M. and van Kammen, Daniel P. and Peters, Perry and Hacksell, Uli},
	year = {2012},
	month = {11},
	date = {2012-11},
	journal = {Schizophrenia Research},
	pages = {144--152},
	volume = {141},
	number = {2-3},
	doi = {10.1016/j.schres.2012.07.029},
	note = {PMID: 22954754},
	langid = {eng}
}

@article{greenwood2021,
	title = {Lumateperone: A Novel Antipsychotic for Schizophrenia},
	author = {Greenwood, Jessica and Acharya, Rucha B. and Marcellus, Valerie and Rey, Jose A.},
	year = {2021},
	month = {01},
	date = {2021-01},
	journal = {Annals of Pharmacotherapy},
	pages = {98--104},
	volume = {55},
	number = {1},
	doi = {10.1177/1060028020936597},
	url = {http://journals.sagepub.com/doi/10.1177/1060028020936597},
	langid = {en}
}
